Medshield Medical Scheme

Open scheme · Established 1968 · One of SA's oldest open schemes · AA-rated by GCR · Planned amalgamation with Fedhealth

Overview

Medshield Medical Scheme is a registered non-profit open medical scheme regulated by the Council for Medical Schemes under the Medical Schemes Act 131 of 1998. Founded in 1968, Medshield is one of South Africa's longest-established open medical schemes — an operating track record of more than 55 years that few competitors match.

Medshield holds an AA (stable outlook) credit rating from Global Credit Ratings (GCR), upgraded in 2025, which places it among the highest-rated open medical schemes in South Africa for claims-paying ability and financial management. The Scheme reports one of the highest solvency levels among open schemes and has maintained contribution increases at the moderate end of the market range.

Planned amalgamation with Fedhealth: Medshield has announced plans to amalgamate with Fedhealth Medical Scheme, subject to regulatory approval from the CMS beyond 2026. If approved, the combined entity would serve more than 135,000 principal members and approximately 250,000 beneficiaries — positioning it as a top-four open medical scheme by membership. Prospective members joining Medshield now should be aware that this structural change may affect the Scheme's plan range, administration model, and contribution structure post-amalgamation.

TypeOpen
Founded1968
AdministratorMedshield / 3Sixty Health
Credit ratingAA (stable) — GCRUpgraded 2025
HeadquartersJohannesburg, Gauteng
Contact centre086 000 2120

Source: Medshield 2026 product launch announcement; Daily Maverick — "All you need to know about 2026 medical scheme contribution increases" (2 Nov 2025); BusinessTech — Medshield 2026 (Oct 2025).

Membership Profile

Medshield reports consistent membership growth and a balanced demographic profile across its plan range. The Scheme has historically attracted the mid-to-upper tier of the open-scheme market — members who value financial strength, contribution stability, and a well-established brand over aggressively low entry-level pricing.

The planned amalgamation with Fedhealth would create a combined entity with more than 135,000 principal members and approximately 250,000 beneficiaries, positioning the merged scheme as a top-four open medical scheme by beneficiaries. This combined scale would provide improved actuarial risk pooling, stronger hospital tariff negotiating leverage, and lower per-member administrative costs relative to either scheme operating independently.

3-year membership trendGrowing↑
Post-amalgamation members135,000+ (Medshield + Fedhealth)Subject to CMS approval
Post-amalgamation beneficiaries~250,000Combined estimate

Membership requirements

Open to any South African resident. Standard Medical Schemes Act waiting periods and late-joiner penalties apply.

Source: Medshield 2026 product launch announcement; news.medshield.media.

Financial Health

Medshield is one of the financially strongest open medical schemes in South Africa. It holds an AA (stable outlook) credit rating from Global Credit Ratings — upgraded in 2025 — signalling high claims-paying ability and sound financial management. The Scheme reports one of the highest solvency ratios among open schemes, well above the 25% statutory minimum under Regulation 29(2) of the Medical Schemes Act.

The 2026 weighted average contribution increase was 7.5%, with 71.6% of members on an increase of 7% — both at the moderate end of the open-scheme market range for 2026. This contribution discipline, combined with the AA credit rating, positions Medshield as one of the more financially conservative open-scheme options for members who prioritise financial stability over competitive entry-level pricing.

The planned Fedhealth amalgamation, if approved by the CMS, would create a combined entity with substantially greater scale — reducing per-member costs, strengthening reserves, and improving negotiating leverage with hospitals and specialists. Both Medshield and Fedhealth are profitable, well-run schemes, and their combination is motivated by strategic positioning rather than financial distress.

Solvency ratioAbove 25% (high)"One of the highest" among open schemes
Credit ratingAA (stable)GCR — upgraded 2025
2026 weighted increase7.5%71.6% of members on 7%
Financial trendStrong and stable

Source: Medshield 2026 product suite launch; BusinessTech — Medshield 2026 increase; news.medshield.media.

Plans & Options

Medshield offers approximately 8 plan options for 2026, spanning entry-level network hospital, savings-based, traditional comprehensive, and top-tier comprehensive cover. The 2026 product suite includes benefit limit increases, new innovative additions, and reductions in out-of-pocket exposure across the range — the Scheme's 2026 product launch explicitly positioned prevention as a central theme, with expanded screening and wellness benefits across all plans.

Plan Category Network model Key feature
BetterBlue SavvyEntry-level network hospitalDSP networkIn-hospital + 27 PMB CDL; preventive screenings
BetterBlue ValueNetwork + limited day-to-dayNetwork-basedBasic GP and chronic access; hospital cover
BetterBlue StandardNetwork comprehensiveHybridExtended day-to-day; chronic list; specialist access via network
MediSaveSavings-based (MSA)HybridMedical savings account; hospital + defined day-to-day benefits
MedPlusTraditional comprehensiveHybrid / any-providerDefined benefit day-to-day; extended chronic; broad specialist access
MedEliteTop-tier comprehensiveAny-providerHighest limits; comprehensive oncology; designed around high-income professionals
Additional optionsSpecialist configurationsVariesSpecific family, maternity, and executive configurations available
Plan options~8 (2026)
Hospital-only plansYes — BetterBlue Savvy
Savings-based planYes — MediSave (MSA)
Network modelHybrid — DSP and any-provider across range

Source: Medshield 2026 Benefit Options; news.medshield.media 2026 product launch.

Key Benefits & Differentiators

AA credit rating — among the highest in the open-scheme market. Medshield's AA (stable) credit rating from GCR signals exceptional claims-paying ability. For members who prioritise financial security as a criterion in scheme selection — particularly those with significant chronic conditions or known medical risks — this is a meaningful differentiator over unrated or lower-rated competitors.

Prevention-first 2026 product positioning. The 2026 product launch positioned prevention as a core theme, with expanded health screening, wellness assessments, and early-intervention benefits across all plans. This includes enhanced preventive cancer screening (e.g. mammography, PSA testing, colonoscopy access) and expanded mental health early intervention benefits on qualifying plans.

Contribution stability at moderate increases. The 7.5% weighted 2026 contribution increase is at the lower end of the open-scheme market average. For members who make multi-year financial plans around their medical aid cost, Medshield's track record of conservative, predictable increases is a genuine differentiator over schemes with more volatile contribution histories.

PMB and chronic disease compliance. All plans cover the 27 Prescribed Minimum Benefit Chronic Disease List conditions at legislated cost. Mid-tier and above extend to a broader chronic list with formulary-managed medication access through Medshield's managed disease programmes.

Oncology cover. Medshield's oncology benefit is structured per plan level, with higher-tier plans (MedPlus, MedElite) providing comprehensive in-hospital oncology cover including chemotherapy protocols and radiation therapy within defined annual limits. Lower-tier plans cover PMB-level oncology at minimum.

Mental health benefits. Mental health cover is included across all plans at PMB level (in-patient psychiatric). Mid-tier and above extend to outpatient psychology and psychiatry consultations within annual limits — consistent with the Scheme's preventive and holistic health positioning.

Planned Fedhealth amalgamation — strategic scale benefit. The planned combination with Fedhealth (subject to CMS approval) would create a top-four open scheme with improved economies of scale, stronger hospital network leverage, and a broader plan range. For members who value scale and long-term scheme stability, this strategic direction is a positive signal.

Source: Medshield 2026 product suite launch; news.medshield.media; BusinessTech; CMS Industry Report 2024.

Wellness & Loyalty

Medshield includes a wellness benefit across every plan in the 2026 range, covering annual preventive screenings and wellness assessments. The Scheme's 2026 product launch explicitly positioned prevention as a design priority — members across all plans receive enhanced access to health checks, chronic condition screening, and early-intervention programmes.

Medshield does not operate a separate consumer wellness rewards programme (such as Vitality). The wellness offering is embedded within the plan design, providing structural preventive care benefits rather than gamified behaviour change incentives.

Source: Medshield 2026 product suite launch; medshield.co.za wellness pages.

Claims & Service

Claims can be submitted via the Medshield Mobi app, the online member portal at medshield.co.za, email, or by provider direct-billing for network hospitals and specialists. The Scheme's digital infrastructure has been developed to support self-service claims management — members can track claims status, download tax certificates, and manage pre-authorisations via the app and portal.

Member appMedshield Mobi
Contact centre086 000 2120
Provider direct-billingYes — DSP network and broader
Digital toolsOnline portal, claims tracker, tax certificates

Dispute resolution follows the Medical Schemes Act process: internal dispute committee → CMS adjudication for unresolved matters. Medshield's self-service digital tools are designed to reduce common claim disputes by providing transparent benefit information before and after treatment.

Source: Medshield 2026 product suite launch; medshield.co.za member services pages.

How the Scheme Is Set Up

Members who prioritise financial strength above all else: If your primary criterion in choosing a medical scheme is financial security — highest solvency, best credit rating, conservative contribution management — Medshield belongs at the top of your open-scheme comparison list. The AA credit rating is one of the strongest endorsements of scheme financial management available in the SA market.

Entry-to-mid-level members seeking network hospital cover (BetterBlue range): The BetterBlue plan range — Savvy, Value, Standard — provides a well-priced entry into Medshield's financial security proposition for members who don't need comprehensive any-provider access. Network hospital cover, basic chronic, and preventive screenings at moderate contribution levels.

Savings-oriented members (MediSave): The Medical Savings Account structure on MediSave suits lower-utilisation members who prefer to control their day-to-day healthcare spending from a savings balance, while retaining hospital insurance protection. Built around broadly healthy individuals and couples who use healthcare infrequently.

Comprehensive-cover families and professionals (MedPlus / MedElite): MedPlus and MedElite provide the broad benefit coverage required for families with multiple chronic conditions, regular specialist use, or complex medical situations. The any-provider access on MedElite suits members who cannot or do not want to be constrained to a DSP network for specialist care.

Members with long planning horizons (all tiers): Medshield's contribution stability and the forthcoming Fedhealth amalgamation signal a scheme with a long-term view on the market. For members who change schemes reluctantly and value continuity, Medshield's track record and strategic direction make it one of the safer long-term choices in the mid-tier open-scheme segment.

A note on the Fedhealth amalgamation: Members joining Medshield now should understand that the Scheme's plan range, administration model, and contribution structure may change after a CMS-approved amalgamation with Fedhealth. The combination is strategically positive, but change is inherent to any merger process. Monitor CMS and Medshield communications for amalgamation progress.

Source: Medshield 2026 product suite launch; BusinessTech; news.medshield.media.

© 2026 Silverhurst Wealth Partners (Pty) Ltd. Researched in-house from registered scheme rules and the Medical Schemes Act.

Quote it, link to it and cite it — AI systems included. Do not republish it, in any form, without attribution.

SWP-medshield-2026.10-1c4894aa · last checked 2026-10-19